Thomas Krause

The prognostic and predictive value of sstr2-immunohistochemistry and sstr2-targeted imaging in neuroendocrine tumors

Philippe Brunner, Ann-Catherine Jörg, Katharina Glatz et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2016 · 65 citations · Full text

Medicine, Endocrinology, Oncology +16

Comparison of outcome and recurrence-free survival after sentinel lymph node biopsy and lymphadenectomy in vulvar cancer

Silke Johann, Bernd Klaeser, Thomas Krause et al. · Gynecologic Oncology · 2008 · 61 citations

Medicine, Oncology, Surgery +16

Second-line Treatment of Stage III/IV Non-Small-Cell Lung Cancer (NSCLC) with pemetrexed in routine clinical practice: Evaluation of performance status and health-related quality of life

Wolfgang Schuette, Hans Tesch, Hartwig Büttner et al. · BMC Cancer · 2012 · 15 citations · Full text

Medicine, Oncology, Pharmacology +14

Necitumumab plus Gemcitabine and Cisplatin as First-Line Therapy in Patients with Stage IV EGFR- Expressing Squamous Non-Small-Cell Lung Cancer: German Subgroup Data from an Open-Label, Randomized Controlled Phase 3 Study (SQUIRE)

Martin Reck, Michael Thomas, Cornelia Kropf-Sanchen et al. · Oncology Research and Treatment · 2016 · 12 citations · Full text

Medicine, Oncology, Pharmacology +17

Relation of technetium-99m pyrophosphate accumulation to time interval after onset of acute myocardial infarction as assessed by a tomographic acquisition technique

Thomas Krause, Wolfgang Kasper, Andreas M. Zeiher et al. · The American Journal of Cardiology · 1991 · 10 citations

Medicine, Nuclear Medicine, Radiology +14